pentobarbital will lessen the extent or influence of diazepam intranasal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check. Strong or average CYP3A4 inducers may raise charge of diazepam elimination; therefore, efficacy of diazepam might be reduced.
Watch Closely (1)pentobarbital will raise the degree or result of clopidogrel by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will lower the level or influence of theophylline by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
pentobarbital will reduce the extent or outcome of bosentan by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unidentified.
If inducer is discontinued, look at oliceridine dosage reduction and keep track of for indications of respiratory depression.
pentobarbital will decrease the level or effect of quetiapine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
pentobarbital will reduce the extent or result of estropipate by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
pentobarbital will reduce the level or result of pazopanib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
pentobarbital decreases levels of ponatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. Stay away from Except if the coadministration outweighs the probable risk of click here ponatinib underexposure; keep track of for signs of diminished efficacy.
With therapeutic doses of TCAs, barbiturates enhance metabolism and decrease blood concentrations of TCAs.
pentobarbital will reduce the extent or influence of atazanavir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Unidentified.
pentobarbital will lower the extent or result of cariprazine by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
With therapeutic doses of TCAs, barbiturates boost metabolism and decrease blood concentrations of TCAs.
pentobarbital will lessen the level or influence of ramelteon by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Unidentified.